Transcept Pharma (TSPT) Taps John Kollins as CBO

Article Stock Quotes (1) Comments (0)

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), reports that John A. Kollins will join the Company, effective June 1, 2012, and serve as Senior Vice President and Chief Business Officer. In this new position, Mr. Kollins will have primary responsibility for business and corporate development activities and report to Glenn A. Oclassen, President and Chief Executive Officer of Transcept.

Kollins provided strategy, business development and transaction services to life science companies via Parnassus Advisors, the consulting and advisory firm he established, and Locust Walk Partners. From 2007 to 2009, he served successively as Chief Business Officer, Chief Operating Officer, and Chief Executive Officer and Director of OXiGENE, a publicly-held biopharmaceutical company.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• JPMorgan (JPM) Shareholders Support Dimon in Dual Role
• Forest Labs (FRX) CEO to Retire at End of Year
• HP (HPQ) Names Murrin Treasurer after McMullen Retires

Create E-mail Alert Related Categories

Management Changes

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?